Bioventus (BVS) Announces CFO to Step Down
Get Alerts BVS Hot Sheet
Join SI Premium – FREE
Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Greg Anglum is transitioning from his role as Senior Vice President and Chief Financial Officer (CFO) to pursue other career opportunities. To ensure a smooth transition, Mr. Anglum will remain in his current role until a successor is named.
“I want to thank Greg for his dedication to Bioventus over the past five years,” commented Ken Reali, Bioventus’ Chief Executive Officer. “I am grateful for his contributions through our initial public offering and our recent acquisitions of Bioness and Misonix. Greg has instilled the appropriate financial controls as we have made the transition to a public entity, and his efforts to strengthen our balance sheet have positioned us well to continue to invest in an innovative, rapidly growing active healing portfolio. We are working diligently to identify a CFO who brings robust experience leading a rapidly expanding organization and can work with me and my executive team to help take Bioventus to the next level of growth by enhancing the results-driven foundation and culture that we have built.”
Mr. Anglum said, “As I begin the next chapter of my career, I am grateful for my experience working with Ken and the talented team at Bioventus. It has been a privilege to work alongside these dedicated individuals to bring innovative active healing solutions to market and improve the lives of countless patients.”
Bioventus has been actively working with Spencer Stuart to identify a successor to Mr. Anglum.
Mr. Anglum’s departure is unrelated to Bioventus’ business performance, financial reporting, or controls, and the Company is reaffirming its previously issued 2021 financial guidance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyCorp names Chris Doll as chief strategy officer and deputy CFO
- Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and The Simply Good Foods Company (NASDAQ: SMPL);
- Greenbrier names Brian Comstock as next CEO as Tekorius retires
Create E-mail Alert Related Categories
Corporate News, Management ChangesRelated Entities
Twitter, Earnings, Definitive Agreement, IPO, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share